Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 177, iss. 3

التفاصيل البيبلوغرافية
Parent link:Bulletin of Experimental Biology and Medicine=Бюллетень экспериментальной биологии и медицины.— .— New York: Springer Science+Business Media LLC.
Vol. 177, iss. 3.— 2024.— P. 344–348
مؤلف مشترك: National Research Tomsk Polytechnic University (570)
مؤلفون آخرون: Chernysheva, Smol’iakova V. I. Vera Ivanovna, Plotnikov M. B., Ulyakhina O. A., Osipenko A. N. Anton Nikolaevich, Kovrizhina A. R. Anastasia Ruslanovna, Khlebnikov A. I. Andrey Ivanovich
الملخص:Title screen
The neuroprotective activity of tryptanthrin and its oxime was compared in male Wistar rats with a model of intraluminal occlusion of the middle cerebral artery. Neurobehavioral tests were performed 4, 24, and 48 h after focal cerebral infarction (FCI) using a modified neurological severity score (mNSS); additionally, the horizontal stability test, the plantar sensitivity test of the fore and hind limbs, holding on the tilted cage top test, and negative geotaxis test were performed. The size of FCI and the severity of brain tissue swelling were examined on day 2 after occlusion. Tryptanthrin and its oxime were administered at a dose of 10 mg/kg intraperitoneally during FCI, then daily for 2 days. In the control group, the mean score of neurological deficit remained at a high level for 2 days. FCI size was 43.8±3.4% of hemisphere area, and the hemisphere volume increased by 18.5±2.0% due to brain tissue swelling and edema. Administration of tryptanthrin and its oxime significantly decreased neurological deficits at all control points and reduced FCI size (by 24.2 and 30.4%, respectively) and brain tissue swelling of the affected hemisphere (by 64.9 and 62.7%, respectively). Therefore, the neuroprotective effect of tryptanthrine and its oxime in the acute period of FCI is largely determined by their anti-inflammatory activity
Текстовый файл
AM_Agreement
اللغة:الإنجليزية
منشور في: 2024
الموضوعات:
الوصول للمادة أونلاين:https://doi.org/10.1007/s10517-024-06186-w
Статья на русском языке
التنسيق: الكتروني فصل الكتاب
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=675573

MARC

LEADER 00000naa0a2200000 4500
001 675573
005 20241016113739.0
090 |a 675573 
100 |a 20241016a2024 k||y0engy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats  |f G. A. Chernysheva, V. I. Smolyakova, M. B. Plotnikov [et al.]  |d Сравнительная оценка нейропротекторной активности триптантрина и его оксима при окклюзии средней мозговой артерии у крыс  |z rus 
203 |a Текст  |c электронный  |b визуальный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 20 tit 
330 |a The neuroprotective activity of tryptanthrin and its oxime was compared in male Wistar rats with a model of intraluminal occlusion of the middle cerebral artery. Neurobehavioral tests were performed 4, 24, and 48 h after focal cerebral infarction (FCI) using a modified neurological severity score (mNSS); additionally, the horizontal stability test, the plantar sensitivity test of the fore and hind limbs, holding on the tilted cage top test, and negative geotaxis test were performed. The size of FCI and the severity of brain tissue swelling were examined on day 2 after occlusion. Tryptanthrin and its oxime were administered at a dose of 10 mg/kg intraperitoneally during FCI, then daily for 2 days. In the control group, the mean score of neurological deficit remained at a high level for 2 days. FCI size was 43.8±3.4% of hemisphere area, and the hemisphere volume increased by 18.5±2.0% due to brain tissue swelling and edema. Administration of tryptanthrin and its oxime significantly decreased neurological deficits at all control points and reduced FCI size (by 24.2 and 30.4%, respectively) and brain tissue swelling of the affected hemisphere (by 64.9 and 62.7%, respectively). Therefore, the neuroprotective effect of tryptanthrine and its oxime in the acute period of FCI is largely determined by their anti-inflammatory activity 
336 |a Текстовый файл 
371 0 |a AM_Agreement 
461 1 |t Bulletin of Experimental Biology and Medicine  |c New York  |n Springer Science+Business Media LLC.  |l Бюллетень экспериментальной биологии и медицины 
463 1 |t Vol. 177, iss. 3  |v P. 344–348  |d 2024 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a brain infarction 
610 1 |a neuroprotection 
610 1 |a tryptanthrin 
610 1 |a tryptanthrin oxime 
610 1 |a rats 
701 1 |a Chernysheva   |3 G. A. 
701 1 |a Smol’iakova  |b V. I.  |g Vera Ivanovna 
701 1 |a Plotnikov  |b M. B. 
701 1 |a Ulyakhina  |b O. A. 
701 1 |a Osipenko   |b A. N.  |g Anton Nikolaevich 
701 1 |a Kovrizhina  |b A. R.  |c biotechnology specialist  |c Research Engineer of Tomsk Polytechnic University  |f 1995-  |g Anastasia Ruslanovna  |9 22266 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |9 17500 
712 0 2 |a National Research Tomsk Polytechnic University  |c (2009- )  |9 27197  |4 570 
801 0 |a RU  |b 63413507  |c 20241016  |g RCR 
856 4 |u https://doi.org/10.1007/s10517-024-06186-w  |z https://doi.org/10.1007/s10517-024-06186-w 
856 4 |u https://doi.org/10.47056/0365-9615-2024-177-3-335-339  |z Статья на русском языке 
942 |c CR